A Lancet Commission to address the global burden of hearing loss
[...]prevention or treatment of hearing loss in midlife (45–65 years) or later could reduce the incidence of dementia by as much as 9·1%.3 Thus, prevention and treatment of hearing loss are particularly important at the two ends of the age spectrum. [...]the world's population is increasing and...
Gespeichert in:
Veröffentlicht in: | The Lancet (British edition) 2019-05, Vol.393 (10186), p.2106-2108 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | [...]prevention or treatment of hearing loss in midlife (45–65 years) or later could reduce the incidence of dementia by as much as 9·1%.3 Thus, prevention and treatment of hearing loss are particularly important at the two ends of the age spectrum. [...]the world's population is increasing and ageing, which underscores the need for prevention and treatment in the later years. The attention includes the Review and Editorials in The Lancet;2,4,5 a 2015 letter report from the US President's Council of Advisors on Science and Technology on “aging America and hearing loss: imperative of improved hearing technology”;6 a comprehensive report in 2016 by the US National Academies of Sciences, Engineering, and Medicine on Hearing health care for adults: priorities for improved access and affordability;7 a detailed report by WHO in 2017 on the global costs of unaddressed hearing loss (estimated to be US$750–790 billion annually);8 ratification in 2017 by the World Health Assembly (WHA) of a “Resolution and action plan for prevention of deafness and hearing loss”;9 signing into law of the “Over-the-counter hearing aid act” by the US President in 2017; calls to action we have made with colleagues;10,11 and in 2019 development by WHO and the International Telecommunication Union of an international standard for permissible sound exposures to protect an estimated 1·1 billion people aged 12–35 years against damagingly loud exposures from personal audio devices.12 The purposes of this Lancet Commission are to accelerate the present momentum and to examine how to reduce the global burden of hearing loss. Principal support for this Commission has been provided by the Provost's Office, the School of Medicine, the Chancellor for Health Affairs, the Pratt School of Engineering, the Duke Global Health Institute, the Duke Clinical & Translational Science Institute, and the Division of Head and Neck Surgery and Communication Sciences at Duke University in Durham, NC, USA. |
---|---|
ISSN: | 0140-6736 1474-547X |
DOI: | 10.1016/S0140-6736(19)30484-2 |